The annual Point-to-Point steeplechase in early May transforms the grounds into a festive scene reminiscent of “Downton Abbey ...

Scholar Rock’s stock is due to drop by 7.49% following the news, according to pre-market estimates. CAMBRIDGE, Mass., March 16, 2025--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical ...

Shares in Scholar Rock have gone into overdrive after the biotech reported positive phase 3 results with apitegromab in patients with spinal muscular atrophy (SMA), setting up regulatory filings ...

The Crossroads Chamber of Commerce honored businesses and businesspeople from across Northwest Indiana at its 5th Annual ...

Scholar Rock (NASDAQ: SRRK; the "Company"), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other ...

This month marks the fifth anniversary of the pandemic. We asked students how their lives are different today because of it. By The Learning Network President Trump abruptly stopped providing ...

1 Day SRRK -1.75% DJIA 0.08% S&P Mid Cap 400 -0.51% Health Care/Life Sciences 0.25% ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Get the best of the Pacific in your inbox!